SRC-3 is a novel regulator of human immune T regulatory cells
Covid-19: What happened to randomised controlled trials?
11 February 2021Study: New prostate cancer test could avoid unnecessary biopsies
11 February 2021SRC-3 is a novel regulator of human immune T regulatory cells
A study led by researchers at Baylor College of Medicine reveals a novel role of the steroid receptor coactivator 3 (SRC-3/NCOA3), a protein crucial for steroid hormone function and a prognostic marker for aggressive human breast and other cancers.
